Single- and multiple-dose pharmacokinetics, potential for CYP3A inhibition, and food effect in patients with cancer and healthy subjects receiving ipatasertib Vikram MalhiNageshwar BudhaLuna Musib Original Article 01 September 2021 Pages: 921 - 930
The use of vitamin E in preventing taxane-induced peripheral neuropathy Muhammad Ali HeibaSoheir Sayed IsmailKhaled Abdel-Aziz Kamal Original Article 01 September 2021 Pages: 931 - 939
Impact of fedratinib on the pharmacokinetics of transporter probe substrates using a cocktail approach Ken OgasawaraRebecca N. Wood-HorrallGopal Krishna Original Article 03 September 2021 Pages: 941 - 952
Zileuton inhibits arachidonate-5-lipoxygenase to exert antitumor effects in preclinical cervical cancer models Liling LiYifang XiaoShaoshuai Wang Original Article 03 September 2021 Pages: 953 - 960
Human placental extract ameliorates methotrexate-induced hepatotoxicity in rats via regulating antioxidative and anti-inflammatory responses Mamdooh GhoneumMohamed S. A. El-Gerbed Original Article Open access 10 September 2021 Pages: 961 - 971
Ruxolitinib exposure in patients with acute and chronic graft versus host disease in routine clinical practice—a prospective single-center trial Nora IsbernerSabrina KrausOliver Scherf-Clavel Original Article Open access 10 September 2021 Pages: 973 - 983
Megestrol acetate is a specific inducer of CYP3A4 mediated by human pregnane X receptor Yakun ChenYong TangDaotai Nie Original Article 15 September 2021 Pages: 985 - 996
Population pharmacokinetic analysis of entrectinib in pediatric and adult patients with advanced/metastatic solid tumors: support of new drug application submission Mario González-SalesNassim DjebliFrançois Mercier Original Article 18 September 2021 Pages: 997 - 1007
Population pharmacokinetic analysis of crizotinib in children with progressive/recurrent high-grade and diffuse intrinsic pontine gliomas Elizabeth G. GibsonOlivia CampagneClinton F. Stewart Original Article 29 September 2021 Pages: 1009 - 1020
EVs delivery of miR-1915-3p improves the chemotherapeutic efficacy of oxaliplatin in colorectal cancer Zhenhuan XiaoYun LiuSongzhi Wei Original Article 02 October 2021 Pages: 1021 - 1031
Phase I/II study to assess the clinical pharmacology and safety of single ascending and multiple subcutaneous doses of PF-06881894 in women with non-distantly metastatic breast cancer Hsuan-Ming YaoSarah Ruta JonesFaith D. Ottery Original Article Open access 07 October 2021 Pages: 1033 - 1048
Pretherapeutic screening for Dihydropyrimidine deshydrogenase deficiency in measuring uracilemia in dialysis patients leads to a high rate of falsely positive results Clotilde GaibleCéline NarjozNicolas Pallet Short Communication 13 September 2021 Pages: 1049 - 1053
Correction to: Aurora B kinase as a therapeutic target in acute lymphoblastic leukemia Hiroaki GotoYuki YoshinoShoko Goto Correction 18 July 2021 Pages: 1055 - 1056